Nautilus Biotechnology (NAUT) to Release Quarterly Earnings on Tuesday

Nautilus Biotechnology (NASDAQ:NAUT) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, July 30th. Analysts expect Nautilus Biotechnology to post earnings of ($0.16) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Nautilus Biotechnology (NASDAQ:NAUT) last posted its quarterly earnings data on Tuesday, April 30th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.01. On average, analysts expect Nautilus Biotechnology to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Nautilus Biotechnology Trading Up 1.4 %

NASDAQ:NAUT opened at $2.92 on Monday. The firm has a market cap of $365.76 million, a P/E ratio of -5.31 and a beta of 1.20. The stock has a 50 day moving average of $2.56 and a two-hundred day moving average of $2.68. Nautilus Biotechnology has a 12 month low of $2.19 and a 12 month high of $4.00.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Jefferies Financial Group began coverage on Nautilus Biotechnology in a report on Monday, June 3rd. They issued a “hold” rating and a $3.00 price objective on the stock. Guggenheim assumed coverage on shares of Nautilus Biotechnology in a research note on Thursday, June 27th. They set a “buy” rating and a $6.00 price objective for the company.

About Nautilus Biotechnology

Nautilus Biotechnology, Inc, a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis.